YOON; Yeup

Patent Applications and Registrations

Patent applications and USPTO patent grants for YOON; Yeup.The latest application filed is for "antibody specifically binding to c-met, and use thereof".

Company Profile

1.6.14

YOON; Yeup - Seoul KR
Yoon; Yeup - Yongin-si N/A KR
YOON; Yeup - Gyeonggi-do KR
Yoon; Yeup - Kwacheon-si KR
YOON; Yeup - Gwacheon-si KR
Yoon; Yeup - Kwacheon-shi KR
Yoon; Yeup - Kwacheon KR
Yoon; Yeup - Gyunggi-Do KR
Yoon, Yeup - Kyungki-do KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody Specifically Binding To C-met, And Use Thereof App 20210363262 - NAM; Do-Hyun ; et al.	2021-11-25
Antibody binding to neuropilin 1 and use thereof Grant 10,364,289 - Nam , et al.	2019-07-30
Screening and engineering method of super-stable immunoglobulin variable domains and their uses Grant 10,078,085 - Lim , et al. September 18, 2	2018-09-18
Antibody Binding To Neuropilin 1 And Use Thereof App 20170291948 - Nam; Do-Hyun ; et al.	2017-10-12
Screening And Engineering Method Of Super-stable Immunoglobulin Variable Domains And Their Uses App 20160003844 - LIM; Hyung-Kwon ; et al.	2016-01-07
Full Genome Dna Of Human Cytomegalovirus Strain Jhc Isolated From Korean Patient And Open Reading Frames Thereof App 20120237921 - LEE; Chan Hee ; et al.	2012-09-20
Linear Double-stranded Rna Molecule Interfering With Different Target Genes App 20110008885 - Kim; Meehyein ; et al.	2011-01-13
Therapeutic Agent Comprising Lipocalin 2 Against Cancer Metastasis, And Methods Of Early Diagnosis And Inhibition Of Cancer Metastasis Using Lipocalin 2 App 20100256073 - Lee; Eun-kyoung ; et al.	2010-10-07
Method For Enhancing Serum Stability And Lowering Immune Response Of Sirna Down-regulating Gene Expression Of Hbv Or Hcv App 20100209491 - Kim; Soo In ; et al.	2010-08-19
Fusion Protein Of Immunoglobulin Fc And Human Apolipoprotein(a) Kringle Fragment App 20100196370 - Yu; Hyun-Kyung ; et al.	2010-08-05
Method For Reducing Fucose Contents Of Recombinant Proteins App 20100003742 - KIM; Jung-Seob ; et al.	2010-01-07
Therapeutic Agent Comprising Lipocalin 2 Against Cancer Metastasis, And Methods Of Early Diagnosis And Inhibition Of Cancer Metastasis Using Lipocalin 2 App 20090311224 - Lee; Eun-kyoung ; et al.	2009-12-17
Expression vector for animal cell Grant 7,422,874 - Kim , et al. September 9, 2	2008-09-09
Anticancer agent Grant 7,285,277 - Kim , et al. October 23, 2	2007-10-23
Expression vector for animal cell containing nuclear matrix attachment region of interferon beta Grant 7,259,010 - Kim , et al. August 21, 2	2007-08-21
Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same App 20070031379 - Lee; Kyu Hyun ; et al.	2007-02-08
Anticancer Agent App 20060013823 - KIM; Jang-Seong ; et al.	2006-01-19
Expression vector for animal cell containing nuclear matrix attachment region of interferon beta App 20040072352 - Kim, Jeong Do ; et al.	2004-04-15
Expression vector using for animal cell App 20040038394 - Kim, Jong-Mook ; et al.	2004-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.